4/A//SEC Filing
Clyburn Frank 4/A
Accession 0001610717-25-000106
CIK 0001628171other
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 6:27 PM ET
Size
5.5 KB
Accession
0001610717-25-000106
Insider Transaction Report
Form 4/AAmended
Clyburn Frank
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-08-05+26,540→ 26,540 totalExercise: $42.48Exp: 2034-08-05→ Common Stock (26,540 underlying)
Footnotes (1)
- [F1]The option becomes exercisable as it vests and the shares subject to the option vest with respect to 1/36 of the shares subject thereto on each monthly anniversary of August 5, 2024, subject to the reporting person's continued employment or service relationship with the Company on each such vesting date.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001763963
Filing Metadata
- Form type
- 4/A
- Filed
- Apr 27, 8:00 PM ET
- Accepted
- Apr 28, 6:27 PM ET
- Size
- 5.5 KB